Skip to main content
Earnings Labs
Zentalis Pharmaceuticals, Inc. logo

Zentalis Pharmaceuticals, Inc. (ZNTL)

NASDAQ·Healthcare·Biotechnology

$3.60

+2.27%

Mkt Cap $269.08M

Analyst Ratings

Buy

2

Hold

0

Sell

0

Price Target (14 analysts)

$10.00

Range $10.00$10.00

Implied Upside

+177.8%

Consensus $10.00 vs current $3.60